IP Library › Granted Patent US 7,524,496
Granted Patent B2
US 7,524,496 · App. 10/877,774 · Granted Apr 28, 2009

Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,524,496
App. No.
10/877,774
Granted
Apr 28, 2009
Kind
B2
Assignments (2)
CHANGE OF NAME Recorded Aug 12, 2008
From: ABGENIX, INC.
To: AMGEN FREMONT INC.
Reel/Frame 021378/0271 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2004
From: WEBER, RICHARD; FENG, XIAO; FOORD, ORIT; GREEN, LARRY; GUDAS, JEAN; KEYT, BRUCE; LIU, YING; RATHANASWAMI, PALANISWAMI; RAYA, ROBERT; YANG, XIAO DONG; CORVALAN, JOSE; FOLTZ, IAN; JIA, XIAO-CHI; KANG, JASPAL; KANG, CHADWICK T.; KLAKAMP, SCOTT L.; SU, QIAOJUAN JANE
To: ABGENIX, INC.
Reel/Frame 015395/0576 →